ARCHIVES

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988